Avandia Safety Limits May Be Lifted

Source: PharmaManufacturing.com

Jun 03, 2013


The GlaxoSmithKline diabetes drug Avandia is being reviewed by the Food and Drug Administration (FDA). Recent analysis has found the drug may not be as risky as once thought. Fear of heart attack linked to the drug impost strict regulations in 2010, but the FDA may lift said restrictions following a vote this week. As a result, restrictions regarding which patients can get a prescription for Avandia may be lifted. Read the full story. 
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments